ASTUTE ORTHOPAEDIC SOLUTIONS LIMITEDActive

Company number 09803066Private limited companyIncorporated 2015

Key figures

£732,932+11.6%
Net assets 2024/25
+20.2%
Average annual growth 2019/20–2024/25
0200 k400 k600 k800 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, ASTUTE ORTHOPAEDIC SOLUTIONS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand397,617381,295503,805617,368564,628
Total assets397,617———836,629
Total liabilities25,65526,40444,152100,848103,697
Net assets / total equity374,102452,106558,248656,587732,932
Average number of employees22220

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ASTUTE ORTHOPAEDIC SOLUTIONS LIMITED

Company

ASTUTE ORTHOPAEDIC SOLUTIONS LIMITED is a private limited company registered with Companies House under company number 09803066. It was incorporated on 1 Oct 2015. Its status is active. The registered office is in Newcastle (ST5). Its nature of business (SIC 2007) is hospital activities (86101).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files small company accounts (filleted). Net assets were £732,932, up 11.6% on the previous year. Cash at bank and in hand was £564,628. Total assets were £836,629 and total liabilities £103,697. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 12 Oct 2027.